Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biofrontera Inc (BFRI)

Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,584
  • Shares Outstanding, K 5,089
  • Annual Sales, $ 34,070 K
  • Annual Income, $ -20,130 K
  • 60-Month Beta 0.46
  • Price/Sales 0.14
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BFRI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -14.96
  • Most Recent Earnings $-1.85 on 05/15/24
  • Next Earnings Date 08/09/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -1.19
  • Number of Estimates 1
  • High Estimate -1.19
  • Low Estimate -1.19
  • Prior Year -6.14
  • Growth Rate Est. (year over year) +80.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8700 +3.45%
on 06/11/24
1.1585 -22.31%
on 05/28/24
-0.1500 (-14.29%)
since 05/24/24
3-Month
0.8700 +3.45%
on 06/11/24
2.4302 -62.97%
on 04/10/24
-0.2800 (-23.73%)
since 03/25/24
52-Week
0.6100 +47.54%
on 02/08/24
12.9857 -93.07%
on 07/24/23
-8.6540 (-90.58%)
since 06/23/23

Most Recent Stories

More News
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand

Palm Beach, FL – October 4, 2022 – FinancialNewsMedia.com News Commentary –  The laser therapy market has been having a very health growth trend in recent years and is expected to continue through...

PIXY : 1.7975 (-8.29%)
EW : 90.40 (+0.26%)
BFRI : 0.9000 (-0.07%)
LITE : 49.41 (+3.85%)
CUTR : 1.4100 (+2.17%)
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand

/PRNewswire/ -- The laser therapy market has been having a very health growth trend in recent years and is expected to continue through the coming years....

PIXY : 1.7975 (-8.29%)
EW : 90.40 (+0.26%)
BFRI : 0.9000 (-0.07%)
LITE : 49.41 (+3.85%)
CUTR : 1.4100 (+2.17%)
Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbH

Patent Improves Differentiated Profile of Ameluz-PDT by Expected Reduced Pain Intensity while Maintaining Efficacy WOBURN, Mass., Aug. 01, 2022 (GLOBE...

BFRI : 0.9000 (-0.07%)
BFRIW : 0.0450 (unch)
Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement

WOBURN, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0450 (unch)
BFRI : 0.9000 (-0.07%)
Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing Excellence

Named Among the 10 Fastest-Growing Life Sciences Companies to Watch in 2022 by CIOCoverage Magazine New Ameluz® Marketing Campaign Receives Gold 2022...

BFRI : 0.9000 (-0.07%)
BFRIW : 0.0450 (unch)
Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conference

WOBURN, Mass., May 31, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0450 (unch)
BFRI : 0.9000 (-0.07%)
New Data and Forecasts for the U.S. Skin Cancer Market Strongly Support the Commercial Opportunity for Biofrontera’s Ameluz®

WOBURN, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0450 (unch)
BFRI : 0.9000 (-0.07%)
Biofrontera Inc. Announces Closing of $9.4 Million Private Placement

WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0450 (unch)
BFRI : 0.9000 (-0.07%)
Biofrontera Inc. to Report First Quarter Financial Results on May 13, 2022

WOBURN, Mass., May 06, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0450 (unch)
BFRI : 0.9000 (-0.07%)
Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium for Cosmetic Advances & Laser Education

Live Demonstration of New RhodoLED® XL to be Featured WOBURN, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a...

BFRIW : 0.0450 (unch)
BFRI : 0.9000 (-0.07%)

Business Summary

Biofrontera Inc. is a biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on the fields of photodynamic therapy and topical antibiotics. The Company's licensed products focus on the treatment of actinic keratoses,...

See More

Key Turning Points

3rd Resistance Point 1.0336
2nd Resistance Point 1.0067
1st Resistance Point 0.9537
Last Price 0.9000
1st Support Level 0.8738
2nd Support Level 0.8469
3rd Support Level 0.7939

See More

52-Week High 12.9857
Fibonacci 61.8% 8.2582
Fibonacci 50% 6.7978
Fibonacci 38.2% 5.3375
Last Price 0.9000
52-Week Low 0.6100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar